Investigating early breast growth in girls aged 6 to 8 years and its environmental influences
Official title: Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context: Clinical and Biological Parameters, Level of Impregnation With Endocrine Disruptors and Evaluation of the Impact of Environmental Health Measures
Run by Lille Catholic University · NCT06083415 · Data updated 2026-11-12
This study looks at why some girls aged 6 to 8 are developing breasts earlier than usual and what environmental factors might be causing it.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 8 Years |
| Sex | Women only |
| Enrollment | 62 (estimated) |
| Sponsor | Lille Catholic University Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Lambersart, Hauts-de-France and 1 other locations) |
| Status | Recruiting |
| Started | May 15, 2023 |
| Main results expected | May 15, 2026 |
| Study ends | May 15, 2027 |
| Registry record updated | March 17, 2026 |
| Trial ID | NCT06083415 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are French-speaking girls aged 6 to 8 years who are experiencing breast development.
✕Probably not a fit
Patients with organic causes of precocious puberty or those with a history of chemotherapy or radiation therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to analyze the phenomenon of early breast development in girls aged 6 to 8 years, focusing on potential environmental factors contributing to this condition. The study will assess various parameters, including adipose tissue, metabolism, endocrine disruptors, and epigenetic modifications. By examining these factors, the trial seeks to understand the impact of environmental health measures on the progression of early puberty. Additionally, data from participants will be explored in experimental models to test potential mechanisms behind these observations.
Why it matters
Potential benefit: If successful, this study could provide insights into the environmental causes of early puberty, leading to better prevention and management strategies for affected girls.
How similar studies have gone: While there is limited data on similar studies, the investigation of environmental factors in early puberty is a growing area of interest, suggesting potential for novel insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
For patients: Inclusion Criteria: * Girls aged 6 to 8 years * Presenting a breast development (isolated or not) * Undergoing scheduled pediatric day hospital care (HDJ) * Who agree to participate in the study * Whose parents agree to their child's participation in the study * French speaking * Whose parents speak French * Affiliated to social security Exclusion Criteria: * Organic brain causes of precocious puberty: History of neurocerebral disease (malformations, developmental abnormalities) * Organic causes of precocious puberty: Mac Cune Albright syndrome, ovarian cyst or tumor and adrenal hyperplasia * History of chemotherapy or radiation therapy * Presenting with a communication disorder * Pregnancy * Persons under protective measures * Persons deprived of liberty for judicial or administrative reasons For controls: Inclusion Criteria: * Girls aged 6 to 8 * Tanner stage 1: Absence of breasts and hairiness * Coming for routine consultation in the pediatric HDJ at Saint-Vincent-de-Paul hospital, or at the BLM practice in Lambersart, or to radiology for an MRI for another medical other medical reason * Agree to participate in the study * Whose parents agree to their child's participation in the the study * French-speaking * Whose parents speak French * Affiliated with social security Exclusion Criteria: * Signs of puberty (Tanner stages 2, 3, 4 and 5 for breast development) breast development) * Previous chemotherapy or radiotherapy * Presenting a communication disorder * Pregnant women * Persons under protective supervision * Persons deprived of their liberty for judicial or administrative reasons
Where it's running
-
Cabinet BLM
Lambersart, Hauts-de-France, France Recruiting -
Saint Vincent hospital
Lille, Hauts-de-France, France Recruiting
Study contacts
- Principal investigator: Patricia RANNAUD-BARTAIRE, PhD — Hôpital Saint-Vincent de Paul
- Study coordinator: Marie-Paule LEBITASY
- Email: lebitasy.marie-paule@ghicl.net
- Phone: 03.20.22.52.69
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cadmium Exposure in Pregnancy and Its Effect on Fetal Growth
This observational study follows pregnant people to see how cadmium exposure relates to fetal growth and birth weight.
-
Probiotic supplement to lower serum PFAS levels in male firefighters
A probiotic supplement containing Streptococcus salivarius is being tested to see if it lowers PFAS levels in male firefighters who have been exposed to PFAS.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
Noninvasive optical-ultrasound imaging to look inside tissues
A safe, light-based imaging method called ultrasound optical tomography (UOT) is tested in healthy volunteers to see how deep it can image and what tissue looks like, with long-term aim of helping breast cancer detection.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
-
PNEUMO-LIBS: Using tissue imaging and AI to explore causes of chronic lung diseases
This study tests whether multi-element tissue imaging with LIBS, plus the AI tool IFF, can help doctors understand possible causes of chronic lung diseases in adults who have had a lung biopsy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.